BriaCell Therapeutics Corp. (BCTX) › Free Cash FlowBriaCell Therapeutics Corp. (BCTX): Free Cash FlowOperating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.-$24.58MYear ended 2024-07-31Period endedFree Cash FlowChange YoYSource filing2024-07-31-$24.58Mn/a2025-10-16, From 2023-08-01Other metrics: R&D ExpenseOperating IncomeDepreciation & AmortizationEBITDANet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingWeighted Average Diluted SharesEPS (Basic)